Preclinical Functional Neuroimaging

neuroPhINDr is our answer to the problem of low translational value of preclinical neuroimaging. With neuroPhINDr, we aim to shorten time-to-market, increase confidence in preclinical results and improve success rates in phase I trials. neuroPhINDr is a set of highly optimised and standardised protocols for data acquisition, processing and analysis. It combines multiple modalities of brain imaging (rsMRI and ASL) and corroborative techniques (EEG) to create a comprehensive fingerprint of CNS effect of a new compound. neuroPhINDr measures. All modalities are acquired in each subject during a single session, maximising experimental output and minimising the requirement for large groups. Data is then processed using a fully automated cloud-based pipeline. One of our experts reviews a comprehensive quality assurance report before data is cleared for analysis. We slash times to deliver results from months to a few weeks through standardisation, optimisation, and automation.